CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 114 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02322255
NCT02322255N/ACompleted

A Natural History, Non-Interventional, Two-Part Study in Subjects With Fibrodysplasia Ossificans Progressiva (FOP)

Clementia Pharmaceuticals Inc.·observational·Posted Dec 23, 2014·Updated Jun 26, 2020

In Brief

An observational study for Fibrodysplasia Ossificans Progressiva. Completed, enrolled 114 participants across 7 sites in 6 countries.

Detailed Summary

Fibrodysplasia Ossificans Progressiva (FOP) is a rare, severely disabling disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) that result in abnormal bone formation in muscles, tendons, and ligaments. Flare-ups begin early in life and may occur spontaneously or after soft tissue trauma, vaccinations, or influenza infections. Recurrent flare-ups progressively restrict movement by locking joints leading to cumulative loss of function and disability. This 3-year, non-interventional, two-part, natural history study is designed to gain insight into total body HO, FOP disease progression, the impact of FOP on subjects' physical functioning, and clinical features and biomarkers that may be useful in the diagnosis and monitoring of disease progression. This natural history study will also provide important information to inform the design of subsequent interventional trials.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesArgentina, Australia, France, Italy, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 23, 2014
Enrollment StartDec 18, 2014
Primary CompletionApr 9, 2020
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 11.5 years ago